A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services
A Natural History Study of Buprenorphine Diversion, Self-Treatment, and Use of Drug Abuse Treatment Services
批准号:
9175607
负责人:
Raminta Daniulaityte
金额:
$56.3万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-07-15 至 2020-04-30
关键词:
AbstinenceAddressAreaBehavior TherapyBuprenorphineClinicalCommunitiesComplexDataData CollectionDiagnostic and Statistical Manual of Mental DisordersDimensionsDrug Abuse Treatment ServicesDrug abuseDrug usageEpidemicFrequenciesHIVHIV riskHealthHepatitis B VirusHepatitis C virusHeroinHeterogeneityIndividualInjection of therapeutic agentInterventionInterviewLengthMethodsMotivationNatural HistoryNatureOhioOpioidOutcomeOverdosePatternPharmaceutical PreparationsPharmacologic SubstancePharmacotherapyPhasePublic HealthQualitative ResearchRecording of previous eventsRecruitment ActivityReportingResearchRisk BehaviorsSamplingServicesSourceStructureTestingWithdrawal SymptomWorkbasedesignfollow-upinnovationinsightinstrumentmeetingsmetropolitannovelopioid useopioid use disorderopioid withdrawaloverdose deathprescription drug abuseprospectivesubstance abuse treatmenttherapy designtrend
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY
There have been substantial increases in the use of diverted buprenorphine (BUP) in the U.S. Research
suggests that increases are driven by people self-treating opioid withdrawal. A growing trend of BUP diversion
represents an important, although little understood, part of the larger prescription drug abuse problem in the
U.S. that is intertwined with the soaring heroin epidemic. The overall purpose of this natural history study is to
describe and analyze the nature and consequences of diverted BUP use among heroin and/or non-medical
pharmaceutical opioid (NMPO) users who meet criteria for DSM-5 opioid use disorder. The study will be
conducted in the Dayton, Ohio, Metropolitan Area, an emerging epicenter of the heroin epidemic. The study
uses a mixed-methods approach. In Phase I (formative research) qualitative data will be collected to inform
Phase II data collection. Phase II (sample recruitment and longitudinal follow-up) builds on a sequential
explanatory mixed-methods design. We will recruit a community-based sample of 400 people with DSM-5
opioid use disorder who have used diverted BUP in the previous 90 days. The quantitative component will
include structured baseline (N=400) and follow-up interviews conducted every six months for two years. The
qualitative component will include 60 semi-structured in-depth qualitative interviews with individuals selected
from the larger sample based on results of Latent Class Analysis (LCA) of baseline quantitative data. The
Specific Aims are to: 1) Describe key dimensions of BUP diversion, motivations and patterns of BUP and
other drug use, HIV/HBV/HCV risk behaviors, history of unintentional overdose, and drug abuse treatment use.
2) Identify trajectories of diverted BUP product use over 24 months and analyze their dynamic relationship to
health-related outcomes, including opioid use/non-use, HIV/HBV/HCV risk behaviors, unintentional overdose,
and drug abuse treatment engagement. Understanding the nature of diverted BUP use and its effects on opioid
use and utilization of substance abuse treatment services has important clinical and public health implications.
The study is highly significant because it will advance our understanding of crucial scientific research
questions on the mechanisms of BUP diversion and relationships between trajectories of diverted BUP use,
length of abstinence from other opioids, HIV risk behaviors, unintentional overdose, and drug abuse treatment
seeking and engagement. It is highly innovative because it will be the first study to provide a longitudinal,
mixed-methods approach to analyze BUP diversion and trajectories of use in the context of complex
interactions between self-treatment behaviors and use of drug abuse treatment services. The mixed-method
design is also novel because we will use LCA analysis results to select the qualitative sample. Our research
questions will provide findings with critical public health impact that could be used to inform the design of
interventions to address the NMPO/heroin epidemics and issues of BUP diversion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Counterfeit Pharmaceuticals: Increased Risks in the Era of Novel Synthetic Opioids and Other Designer Drugs
-
批准号:10506025
-
项目类别:
-
资助金额:$23.57万
-
财政年份:2022
-
负责人:Raminta Daniulaityte
-
依托单位:
Counterfeit Pharmaceuticals: Increased Risks in the Era of Novel Synthetic Opioids and Other Designer Drugs
-
批准号:10598621
-
项目类别:
-
资助金额:$17.97万
-
财政年份:2022
-
负责人:Raminta Daniulaityte
-
依托单位:
Varenicline OTC Trial on Efficacy and Safety
-
批准号:10174897
-
项目类别:
-
资助金额:$34.95万
-
财政年份:2017
-
负责人:Raminta Daniulaityte
-
依托单位:
Characterizing fentanyl outbreaks: Ethnographic and forensic perspectives
-
批准号:9296109
-
项目类别:
-
资助金额:$18.33万
-
财政年份:2016
-
负责人:Raminta Daniulaityte
-
依托单位:
Characterizing fentanyl outbreaks: Ethnographic and forensic perspectives
-
批准号:9220923
-
项目类别:
-
资助金额:$22.45万
-
财政年份:2016
-
负责人:Raminta Daniulaityte
-
依托单位:
Trending: Social media analysis to monitor cannabis and synthetic cannabinoid use
-
批准号:8913112
-
项目类别:
-
资助金额:$46.13万
-
财政年份:2014
-
负责人:Raminta Daniulaityte
-
依托单位:
A Study of Social Web Data on Buprenorphine Abuse Using Semantic Web Technology
-
批准号:8269958
-
项目类别:
-
资助金额:$18.25万
-
财政年份:2011
-
负责人:Raminta Daniulaityte
-
依托单位:
A Study of Social Web Data on Buprenorphine Abuse Using Semantic Web Technology
-
批准号:8190799
-
项目类别:
-
资助金额:$21.9万
-
财政年份:2011
-
负责人:Raminta Daniulaityte
-
依托单位:
海外基金